Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee-Shing Chang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Heart Journal|September 20, 2024
Enrollment strategies in the era of digital revolution: Experience from a remote health management programShahzad Hassan, Lee-Shing Chang, Daniel Gabovitch, et al.
American Heart Journal|January 8, 2025
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapiesAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
American Heart Journal|January 29, 2026
Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney riskLee-Shing Chang, Shahzad Hassan, Jacqueline Chasse, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Heart Journal|September 20, 2024
Enrollment strategies in the era of digital revolution: Experience from a remote health management programShahzad Hassan, Lee-Shing Chang, Daniel Gabovitch, et al.
American Heart Journal|January 8, 2025
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapiesAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
American Heart Journal|January 29, 2026
Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney riskLee-Shing Chang, Shahzad Hassan, Jacqueline Chasse, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
Pageof 2